Skip to main content
. Author manuscript; available in PMC: 2010 Jan 27.
Published in final edited form as: Drug Metab Dispos. 2008 Aug 25;36(11):2211–2218. doi: 10.1124/dmd.108.022863

Fig. 4.

Fig. 4

Reversed phase-HPLC chromatograph of product ion (m/z 501) experiments. Tracings represent organic-soluble metabolites generated during incubation of UGT1A10 and mutants with UDP-glucuronic acid (4 mM) and 750 μM of each substrate [6-hydroxywarfarin (A), 7-hydroxywarfarin (B), and 8-hydroxywarfarin (C), 10-hydroxywarfarin (D)]. Each substrate was incubated individually for 180 min. All other incubation conditions are noted in Materials and Methods.